Product Code: A16839
The global bone void fillers market was valued at $3,228.4 million in 2021, and is projected to reach $7,330.9 million by 2031, registering a CAGR of 8.5% from 2022 to 2031. Bone void filler is a synthetic bone graft substitute, which is used as filler for bone voids in the bone structure and aims to maintain the stability of bone. A bone void is a complication caused due to failure of the bone's self-healing process, thus developing cavity in bone. These bone voids or gaps may be surgically generated osseous defects or any bone defect from traumatic injury. Bone void fillers are absorbable, biocompatible, bioactive and osteoconductive biologic materials, which are used to fill gaps of skeletal system such as extremities, pelvis, and posterolateral spine. The biologic material increases cell proliferation and provides stability to bones, which result in enhancement of bone regeneration for multiple types of orthopedic operations.
The growth of the global bone void fillers market is majorly driven by increase in prevalence of bone diseases such as bone tumor & bone infection, rise in geriatric population, increase in number of orthopedic surgeries, and surge in cases of sports injuries & accidents. Moreover, increase in R&D activities in the healthcare sector and rise in demand for synthetic bone void filler drive the growth of the market. In addition, the widespread use of bone void fillers in the dentistry sector is anticipated to contribute toward the market growth. Increase in prevalence of bone diseases leads to increase in the number of orthopedic surgeries, which further fosters the market growth. For instance, according to the report shared by the International Osteoporosis Foundation (IOF), estimated change in the annual number of osteoporotic fractures from 2019 to 2034 is 24.8%, which will reach to 5.34 million in 2034 from 4.3 million in 2019.
Furthermore, increase in the number of spinal fusions, arthroplasty procedures, and oral surgeries boosts the growth of the bone void fillers market. Moreover, chronic orthopedic diseases require surgeries such as hip and knee replacements. In such surgeries, bone void fillers are used to fill the gaps in bone. Therefore, increase in number of knee replacement surgeries fuels the market growth. For instance, in Canada, the knee and hip replacement surgery is the second most common surgery, as per the report shared by the Canadian Joint Replacement Registry (CJRR). Approximately more than 75,000 knee replacement and 63,000 hip replacement surgeries were performed in Canada from 2019 to 2020. This report further states 2.4% increase in the hip replacement surgery from 2019 to 2020.
On the contrary, low penetration and clinical barriers of bone void fillers are anticipated to hinder the bone void fillers market growth. Moreover, high cost of surgery is anticipated to act as a major restraint of the global market.
Increase in number of key players that focus on launching different forms of bone void fillers and rise in medical tourism support the market growth. Furthermore, people are travelling across the world to get their treatment done at affordable prices. Despite the affordability, people tend to believe not to compromise on the quality of life. Thus, increase in number of specialized hospitals in countries such as Singapore, Japan, China, and India provide good treatment at affordable price, which encourage patients to travel across the world.
The global bone void fillers market is segmented into type, form, application, end user, and region. By type, the market is segregated into demineralized bone matrix, calcium phosphate bone graft substitute, collagen matrix, and others. The others segment includes magnesium bone graft substitution and calcium sulfate bone void filler. On the basis of form, the market is categorized into gel & putty, granules, and others. The others segment includes paste, powder, and liquid. Depending on application, the market is fragmented into spine fusion, bone fracture, and others. The others segment include pelvic surgery and oral surgery. As per end user, the market is differentiated into hospital, specialty clinics, and others. The others segment includes research centers and specialty clinics.
Region wise, is the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the bone void fillers market are Arthrex Inc., Baxter International Companies, DePuy Synthes Companies, Medtronic Plc., NuVasive Inc. Orthofix Medical Inc., Smith and Nephew Plc., Stryker Corporation, Wright Medical Group Inc., and Zimmer Biomet.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the bone void fillers market analysis from 2021 to 2031 to identify the prevailing bone void fillers market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the bone void fillers market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global bone void fillers market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Demineralized bone matrix
- Calcium phosphate bone graft substitute
- Collagen Matrix
- Others
By Form
- Gel and Putty
- Granules
- Others
By Application
- Spine fusion
- Bone fracture
- Others
By End User
- Hospital
- Specialty Clinics
- Others
By Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Arthrex Inc
- Baxter International Inc.
- depuy synthes companies
- Medtronic plc
- NuVasive Inc
- Orthofix Medical Inc
- Smith and Nephew plc
- Stryker Corporation
- Wright Medical Group Inc
- Zimmer Biomet
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: BONE VOID FILLERS MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Demineralized bone matrix
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Calcium phosphate bone graft substitute
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Collagen Matrix
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Others
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
CHAPTER 5: BONE VOID FILLERS MARKET, BY FORM
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Gel and Putty
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Granules
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
CHAPTER 6: BONE VOID FILLERS MARKET, BY APPLICATION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Spine fusion
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Bone fracture
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
CHAPTER 7: BONE VOID FILLERS MARKET, BY END USER
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Hospital
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Specialty Clinics
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- 7.4 Others
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
CHAPTER 8: BONE VOID FILLERS MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Type
- 8.2.3 North America Market size and forecast, by Form
- 8.2.4 North America Market size and forecast, by Application
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
- 8.2.6.1 U.S.
- 8.2.6.1.1 Market size and forecast, by Type
- 8.2.6.1.2 Market size and forecast, by Form
- 8.2.6.1.3 Market size and forecast, by Application
- 8.2.6.1.4 Market size and forecast, by End User
- 8.2.6.2 Canada
- 8.2.6.2.1 Market size and forecast, by Type
- 8.2.6.2.2 Market size and forecast, by Form
- 8.2.6.2.3 Market size and forecast, by Application
- 8.2.6.2.4 Market size and forecast, by End User
- 8.2.6.3 Mexico
- 8.2.6.3.1 Market size and forecast, by Type
- 8.2.6.3.2 Market size and forecast, by Form
- 8.2.6.3.3 Market size and forecast, by Application
- 8.2.6.3.4 Market size and forecast, by End User
- 8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Type
- 8.3.3 Europe Market size and forecast, by Form
- 8.3.4 Europe Market size and forecast, by Application
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
- 8.3.6.1 Germany
- 8.3.6.1.1 Market size and forecast, by Type
- 8.3.6.1.2 Market size and forecast, by Form
- 8.3.6.1.3 Market size and forecast, by Application
- 8.3.6.1.4 Market size and forecast, by End User
- 8.3.6.2 France
- 8.3.6.2.1 Market size and forecast, by Type
- 8.3.6.2.2 Market size and forecast, by Form
- 8.3.6.2.3 Market size and forecast, by Application
- 8.3.6.2.4 Market size and forecast, by End User
- 8.3.6.3 U.K.
- 8.3.6.3.1 Market size and forecast, by Type
- 8.3.6.3.2 Market size and forecast, by Form
- 8.3.6.3.3 Market size and forecast, by Application
- 8.3.6.3.4 Market size and forecast, by End User
- 8.3.6.4 Italy
- 8.3.6.4.1 Market size and forecast, by Type
- 8.3.6.4.2 Market size and forecast, by Form
- 8.3.6.4.3 Market size and forecast, by Application
- 8.3.6.4.4 Market size and forecast, by End User
- 8.3.6.5 Spain
- 8.3.6.5.1 Market size and forecast, by Type
- 8.3.6.5.2 Market size and forecast, by Form
- 8.3.6.5.3 Market size and forecast, by Application
- 8.3.6.5.4 Market size and forecast, by End User
- 8.3.6.6 Rest of Europe
- 8.3.6.6.1 Market size and forecast, by Type
- 8.3.6.6.2 Market size and forecast, by Form
- 8.3.6.6.3 Market size and forecast, by Application
- 8.3.6.6.4 Market size and forecast, by End User
- 8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Type
- 8.4.3 Asia-Pacific Market size and forecast, by Form
- 8.4.4 Asia-Pacific Market size and forecast, by Application
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
- 8.4.6.1 China
- 8.4.6.1.1 Market size and forecast, by Type
- 8.4.6.1.2 Market size and forecast, by Form
- 8.4.6.1.3 Market size and forecast, by Application
- 8.4.6.1.4 Market size and forecast, by End User
- 8.4.6.2 Japan
- 8.4.6.2.1 Market size and forecast, by Type
- 8.4.6.2.2 Market size and forecast, by Form
- 8.4.6.2.3 Market size and forecast, by Application
- 8.4.6.2.4 Market size and forecast, by End User
- 8.4.6.3 India
- 8.4.6.3.1 Market size and forecast, by Type
- 8.4.6.3.2 Market size and forecast, by Form
- 8.4.6.3.3 Market size and forecast, by Application
- 8.4.6.3.4 Market size and forecast, by End User
- 8.4.6.4 Australia
- 8.4.6.4.1 Market size and forecast, by Type
- 8.4.6.4.2 Market size and forecast, by Form
- 8.4.6.4.3 Market size and forecast, by Application
- 8.4.6.4.4 Market size and forecast, by End User
- 8.4.6.5 South Korea
- 8.4.6.5.1 Market size and forecast, by Type
- 8.4.6.5.2 Market size and forecast, by Form
- 8.4.6.5.3 Market size and forecast, by Application
- 8.4.6.5.4 Market size and forecast, by End User
- 8.4.6.6 Rest of Asia-Pacific
- 8.4.6.6.1 Market size and forecast, by Type
- 8.4.6.6.2 Market size and forecast, by Form
- 8.4.6.6.3 Market size and forecast, by Application
- 8.4.6.6.4 Market size and forecast, by End User
- 8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Type
- 8.5.3 LAMEA Market size and forecast, by Form
- 8.5.4 LAMEA Market size and forecast, by Application
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
- 8.5.6.1 Brazil
- 8.5.6.1.1 Market size and forecast, by Type
- 8.5.6.1.2 Market size and forecast, by Form
- 8.5.6.1.3 Market size and forecast, by Application
- 8.5.6.1.4 Market size and forecast, by End User
- 8.5.6.2 Saudi Arabia
- 8.5.6.2.1 Market size and forecast, by Type
- 8.5.6.2.2 Market size and forecast, by Form
- 8.5.6.2.3 Market size and forecast, by Application
- 8.5.6.2.4 Market size and forecast, by End User
- 8.5.6.3 South Africa
- 8.5.6.3.1 Market size and forecast, by Type
- 8.5.6.3.2 Market size and forecast, by Form
- 8.5.6.3.3 Market size and forecast, by Application
- 8.5.6.3.4 Market size and forecast, by End User
- 8.5.6.4 Rest of LAMEA
- 8.5.6.4.1 Market size and forecast, by Type
- 8.5.6.4.2 Market size and forecast, by Form
- 8.5.6.4.3 Market size and forecast, by Application
- 8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Key developments
CHAPTER 10: COMPANY PROFILES
- 10.1 Arthrex Inc
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
- 10.2 Baxter International Inc.
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
- 10.3 depuy synthes companies
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
- 10.4 Medtronic plc
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
- 10.5 NuVasive Inc
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
- 10.6 Orthofix Medical Inc
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
- 10.7 Smith and Nephew plc
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
- 10.8 Stryker Corporation
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
- 10.9 Wright Medical Group Inc
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
- 10.10 Zimmer Biomet
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments